I agree. NP and the team should be discussing long
Post# of 148166
This article is from just a few days ago and clearly the UK is beginning to attack this problem without a current therapeutic solution at hand. Leronlimab to the rescue?
https://inews.co.uk/news/health/long-haul-cov...ion-610519
Why not offer some support? It can't hurt and can only help based on the known safety profile. Would help our standing with the UK for other Leronlimab matters, too.
Sure, it will cost money but we can't sit back and assume any of the things we want to happen are going to happen. As evidenced by the constant shifting of our goal posts over the past few months. We need to keep making strategic moves to show what Leronlimab can do in case we get stonewalled along our other paths. This seems like an easy and relatively "cheap" thing to do. We already have a site up and running with Leronlimab there.
(I do know that we likely won't get completely stonewalled on our other paths but we could keep getting delayed for dumb, political, or whatever reasons and we should always be thinking 5 steps ahead.)